SKI Market

A+| A| A-|

Indian Indices

Sensex

77,708.52 -442.93
( -0.57%)

Global Indices

Nasdaq

52,169.86 -404.11
(-0.77%)

Dow Jones

7,480.34 -74.43
(-0.99%)

Hang Seng

63,887.74 -2,947.80
(-4.41%)

Nikkei 225

10,542.79 -57.58
(-0.54%)

Forex

USD-INR

96.36 0.10
(0.10%)

EUR-INR

110.37 0.25
(0.23%)

GBP-INR

130.11 0.62
(0.47%)

JPY-INR

0.59 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

163.1433353

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

47.57

1579.72

EPS(TTM)

Face Value()

Div & Yield %

20.08

0.02

Back

Sanofi India standalone net profit declines 14.14% in the March 2026 quarter

Apr 29,2026

Net profit of Sanofi India declined 14.14% to Rs 102.60 crore in the quarter ended March 2026 as against Rs 119.50 crore during the previous quarter ended March 2025. Sales declined 11.87% to Rs 472.30 crore in the quarter ended March 2026 as against Rs 535.90 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	472.30	535.90	-12
OPM %	30.24	32.08	-
PBDT	146.90	174.90	-16
PBT	137.90	165.30	-17
NP	102.60	119.50	-14

77,708.52 -442.93 ( -0.57%)

52,169.86 -404.11 (-0.77%)

7,480.34 -74.43 (-0.99%)

63,887.74 -2,947.80 (-4.41%)

10,542.79 -57.58 (-0.54%)

96.36 0.10 (0.10%)

110.37 0.25 (0.23%)

130.11 0.62 (0.47%)

0.59 0.00 (0.06%)